(Q46035577)

English

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

Toyohiko Watanabe

object named as

Toyohiko Watanabe

3

1 reference

ORCID Public Data File 2021

5

object named as

Hiromi Kumon

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

author name string

Teruhiko Yokoyama

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Katsutoshi Uematsu

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Katsumi Sasaki

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Atsushi Nagai

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Okayama Urological Research Group

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Scandinavian Journal of Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

43

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

307-314

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Validation of the urgency perception scale

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicen

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Accuracy of Residual Urine Measurement in Men: Comparison Between Real-Time Ultrasonography and Catheterization

1 reference

https://api.crossref.org/works/10.1080%2F00365590902836740

21 January 2018

Identifiers

10.1080/00365590902836740

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19396723

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46035577&oldid=2112371058"